Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice

Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice: an International E-survey

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04038268

Acronym

CHOICE

Enrollment

400

Registered

2019-07-30

Start date

2019-09-01

Completion date

2020-09-30

Last updated

2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergen Immunotherapy

Keywords

Immunotherapy, Real Clinical Practice, Respiratory disease, Aeroallergens, IgE-dependent hypersensitivity

Brief summary

Background : Allergen Immunotherapy (AIT) is the only etiological treatment for allergic respiratory diseases. In order to improve the competence on the use of AIT, it is important to extend the investigator's knowledge on its use in routine clinical practice, outside the experimental setting of clinical trials, in real life population of patients receiving AIT. Objective: To evaluate the clinical criteria used by treating clinicians and by the patients themselves, when establishing AIT as treatment in a patient with respiratory disease caused by an IgE-dependent-hypersensitivity to aeroallergens Methods: In 6 country (Denmark, France, Germany, Norway, Spain & Sweden), the national coordinator will be directly responsible for selection of Survey Doctor's participants (Investigators). During 12 months: * Firstly, each investigator will complete the Survey Doctor, online, on SurveyMonkey platform to explain what are the key drivers in Allergen Immunotherapy (AIT) selection (Doctors' Questionnaire, DQ). * On the other hand, at each AIT prescription to a patient, doctors will complete the Survey Patient, on the same platform, to explain how and why they have chosen this type of AIT (Patients' Questionnaire, PQ).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

5 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with IgE mediated respiratory allergy * Patients who will initiate any type of aeroallergen AIT according to real life clinical standards of practice * Any type of aeroallergen for AIT will be included : pollen, house dust mite, animal, dander, moulds * Patient who is under the care of the Doctor participating in the survey

Exclusion criteria

* Patients who refuse to give their informed consent * Food immunotherapy * Venom Immunotherapy

Design outcomes

Primary

Measure	Time frame	Description
Clinical criteria in AIT	1 day	Clinical criteria used by treating clinicians and by the patients themselves, when establishing AIT as treatment in a patient with respiratory disease. These are called drivers of prescription. caused by an IgE-dependent-hypersensitivity to aeroallergens Among the different criteria selected by participants, order of priority of AIT drivers will be established

Countries

France

Outcome results